LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Why FDA Is Moving Against Compounded GLP-1 Weight-Loss Drugs in 2026
FDA has stepped up action against compounded GLP-1 weight-loss drugs sold online and through telehealth. Here’s what changed in 2026, why the agency says shortages no longer justify broad copycat compounding, what safety problems it has flagged, and how to protect yourself before…
FDA recalls Silintan joint-pain capsules after hidden meloxicam found in product sold online
FDA says Silintan capsules sold online nationwide contained undeclared meloxicam, an NSAID that can raise the risk of bleeding, ulcers, kidney injury, heart attack, and stroke in some users.
FDA Class I Recall for Some FreeStyle Libre 3 Sensors: What People With Diabetes Should Do Now
The FDA has classified a recall for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors as Class I, its most serious recall type. The issue is falsely low glucose readings from some sensor lots. Here is what is affected, what is…
Mpox Rash in 2026: What New Strain Reports Mean for People in the U.S.
A February 2026 recombinant mpox report has not changed the basic advice for most people in the United States: you cannot tell the strain by looking at a rash, and a new unexplained sore or skin lesion still needs medical evaluation.
What the New Alzheimer’s Blood Tests Can — and Can’t — Tell You About Dementia
New Alzheimer’s blood tests are becoming part of clinical care in the United States, but they are not simple screening tools for anyone worried about forgetfulness. Here’s what the FDA cleared, what specialists recommend, and what families should ask before treating a blood…
Why a Cyberattack on a Medical Device Company Can Affect Patient Care Even If Your Hospital Wasn’t Hacked
Stryker’s March 2026 cyberattack is a reminder that patients can feel the effects of a vendor disruption through shipping delays, manual workarounds, and some rescheduled procedures, even when their hospital was not directly hacked.
A New Oral Gonorrhea Drug Won FDA Approval. What the Zoliflodacin Trial Actually Found
The FDA has approved Nuzolvence, an oral form of zoliflodacin, for some uncomplicated gonorrhea cases. Here is what the phase 3 trial found, what noninferior means, and why this does not apply to every gonorrhea infection.
Medicare’s Diabetes Prevention Program Now Has More Online Options in 2026: Who Qualifies and What It Could Mean for Prediabetes Prevention
A 2026 Medicare policy update gives eligible beneficiaries more ways to join the Medicare Diabetes Prevention Program, including live online and on-demand sessions through December 31, 2029. Here’s who qualifies, what the program includes, what Medicare pays, and why the access change matters…
Boulder City Hospital to End Inpatient Admissions May 1, Public Comment Deadline Nears
Henderson, NV – March 25, 2026 – Boulder City Hospital plans to convert to a Rural Emergency Hospital on May 1, ending inpatient admissions and shifting to 24/7 emergency and ou…
Medicaid Members Face April 1 Plan Change as UnitedHealthcare Exits Louisiana Program
New Orleans, LA – March 25, 2026 – Louisiana Medicaid members enrolled in UnitedHealthcare must select a new plan before April 1 to avoid coverage disruption.
Thinking About Chiropractic for Low Back Pain? What the Newest Evidence Says
A new NCCIH consumer update and a large recent JAMA trial point in the same direction: spinal manipulation may help some people with low back pain, but average benefits are usually small, and it works best as one part of a broader plan…
New U.S. cervical cancer screening guidance adds self-collected HPV testing: who it’s for, what changes in 2026, and when insurance coverage follows
A new federal update says self-collected HPV testing should be offered as an option for average-risk women ages 30 to 65. Here’s what changed, what did not, and why many insurance plans may not have to cover the new option with no out-of-pocket…